Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

Current Biology

Volumn 9, Issue 5, 1999, Pages 273-278

  Köberle, Beate ^a,b   Masters, John R W ^b   Hartley, John A ^c   Wood, Richard D ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0033545701     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9822(99)80118-3     Document Type: Article

References (23)

1. Bosl GJ, Motzer RJ: Testicular germ-cell cancer. W Engl J Med 1997, 337:242-253.
2. Köberle B, Payne J, Grimaldi KA, Hartley JA, Masters JRW: DNA- Repair in cisplatin-sensitive and resistant human cell-lines measured in specific genes by quantitative polymerase chain- Reaction. Biochem Pharmacol 1996, 52:1729-1734.
3. Köberle B, Grimaldi KA, Sunters A, Hartley JA, Kelland LR, Masters JRW: DNA-repair capacity and cisplatin sensitivity of human testis tumor cells. Int J Cancer 1997, 70:551-555.
4. Wood RD: Nucleotide excision repair in mammalian cells. J Biol Chem 1997, 272:23465-23468.
5. Wilson DM, Thompson LH: Life without DNA-repair. Proc Natl Acad Sci USA 1997, 94:12754-12757.
6. Moggs JG, Yarema KJ, Essigmann JM, Wood RD: Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct. J Biol Chem 1996, 271:7177-7186.
7. cdn1. Oncogene 1998, 17:2827-2838.
8. Fraval HNA, Rawlings CJ, Roberts JJ: Increased sensitivity of UV- repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from micrococcus luteus. Mutat Res 1978, 51:121-132.
9. Dijt FJ, Fichtinger-Schepman AMJ, Berends F, Reedijk J: Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human-fibroblasts. Cancer Res 1988, 48:6058-6062.
10. Satokata I, Tanaka K, Yuba S, Okada Y: Identification of splicing mutations of the last nucleotides of exons, a nonsense mutation, and a missense mutation of the XPAC gene as causes of group-a xeroderma-pigmentosum. Mutat Res 1992, 273:203-212.
11. Nakane H, Takeuchi S, Yuba S, Saijo M, Nakatsu Y, Murai H, et al.: High-incidence of ultraviolet-b-induced or chemical-carcinogen- Induced skin tumors in mice lacking the xeroderma- Pigmentosum group-A gene. Nature 1995, 377:165-168.
12. De Vries A, Van Oostrom CTM, Hofhuis FMA, Portant PM, Berg RJW, De Gruijl FR, et al.: Increased susceptibility to ultraviolet-b and carcinogens of mice lacking the DNA excision-repair gene XPA. Nature 1995, 377:169-173.
13. Zhen WP, Evans MK, Haggerty CM, Bohr VA: Deficient gene- Specific repair of cisplatin-induced lesions in xeroderma pigmentosum and fanconi anemia cell lines. Carcinogenesis 1993, 14:919-924.
14. Cleaver JE, Charles WC, McDowell ML, Sadinski WJ, Mitchell DL: Overexpression of the XPA repair gene increases resistance to ultraviolet-radiation in human-cells by selective repair of DNA- Damage. Cancer Res 1995, 55:6152-6160.
15. Myrand SP, Topping RS, States JC: Stable transformation of xeroderma-pigmentosum group-a cells with an XPA minigene restores normal dna-repair and mutagenesis of UV-treated plasmids. Carcinogenesis 1996, 17:1909-1917.
16. Kobayashi T, Takeuchi S, Saijo M, Nakatsu Y, Morioka H, Otsuka E, et al.: Mutational analysis of a function of xeroderma- Pigmentosum group-a (XPA) protein in strand-specific DNA- Repair. Nucleic Acids Res 1998, 26:4662-4668.
17. Masters JRW, Osborne EJ, Walker MC, Parris CN: Hypersensitivity of human testis-tumour cell lines to chemotherapeutic drugs. Int J Cancer 1993, 53:340-346.
18. Chresta CM, Masters JRW, Hickman JA: Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high bax:bcl-2 ratio. Cancer Res 1996, 56:1834-1841.
19. Houldsworth J, Xiao H, Murty Vvvs, Chen WY, Ray B, Reuter VE, et al.: Human male germ-cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene 1998, 16:2345-2349.
20. Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G: Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumour cell lines. Int J Cancer 1997, 73:592-599.
21. Zambie DB, Jacks T, Lippard SJ: P53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells. Proc Natl Acad Sci USA 1998, 95:6163-6168.
22. Layher SK, Cleaver JE: Quantification of XPA gene-expression levels in human and mouse-cell lines by competitive RT-PCR. Mutat Res 1997, 383:9-19.
23. Klungland A, Höss M, Gunz D, Constantinou A, Clarkson SG, Doetsch PW, et al.: Base excision-repair of oxidative DNA damage activated by XPG protein. Mol Cell 1999, 3:33-42.